- freely available
Apoptogenic Metabolites in Fractions of the Benthic Diatom Cocconeis scutellum parva
AbstractBenthic diatoms of the genus Cocconeis contain a specific apoptogenic activity. It triggers a fast destruction of the androgenic gland in the early post-larval life of the marine shrimp Hippolyte inermis, leading to the generation of small females. Previous in vitro investigations demonstrated that crude extracts of these diatoms specifically activate a dose-dependent apoptotic process in human cancer cells (BT20 breast carcinoma) but not in human normal lymphocytes. Here, a bioassay-guided fractionation has been performed to detect the apoptogenic compound(s). Various HPLC separation systems were needed to isolate the active fractions, since the apoptogenic metabolite is highly active, present in low amounts and is masked by abundant but non-active cellular compounds. The activity is due to at least two compounds characterized by different polarities, a hydrophilic and a lipophilic fraction. We purified the lipophilic fraction, which led to the characterization of an active sub-fraction containing a highly lipophilic compound, whose molecular structure has not yet been identified, but is under investigation. The results point to the possible medical uses of the active compound. Once the molecular structure has been identified, the study and modulation of apoptotic processes in various types of cells will be possible.
Share & Cite This Article
Zupo, V.; Jüttner, F.; Maibam, C.; Butera, E.; Blom, J.F. Apoptogenic Metabolites in Fractions of the Benthic Diatom Cocconeis scutellum parva. Mar. Drugs 2014, 12, 547-567.View more citation formats
Zupo V, Jüttner F, Maibam C, Butera E, Blom JF. Apoptogenic Metabolites in Fractions of the Benthic Diatom Cocconeis scutellum parva. Marine Drugs. 2014; 12(1):547-567.Chicago/Turabian Style
Zupo, Valerio; Jüttner, Friedrich; Maibam, Chingoileima; Butera, Emanuela; Blom, Judith F. 2014. "Apoptogenic Metabolites in Fractions of the Benthic Diatom Cocconeis scutellum parva." Mar. Drugs 12, no. 1: 547-567.